SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001628280-24-006346
Filing Date
2024-02-22
Accepted
2024-02-22 16:12:49
Documents
17
Period of Report
2024-02-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K vir-20240221.htm   iXBRL 8-K 31572
2 EX-99.1 a20240222-q4ex991earningsr.htm EX-99.1 177312
7 LOGO virlogo.jpg GRAPHIC 25904
  Complete submission text file 0001628280-24-006346.txt   428128

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vir-20240221.xsd EX-101.SCH 2258
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vir-20240221_def.xml EX-101.DEF 15302
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vir-20240221_lab.xml EX-101.LAB 29663
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vir-20240221_pre.xml EX-101.PRE 16021
18 EXTRACTED XBRL INSTANCE DOCUMENT vir-20240221_htm.xml XML 3339
Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158
Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324
Vir Biotechnology, Inc. (Filer) CIK: 0001706431 (see all company filings)

IRS No.: 812730369 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39083 | Film No.: 24664869
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)